Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus

2021-12-10T11:01:20+00:00

The authorisation holder for dapagliflozin has withdrawn the indication for type 1 diabetes mellitus. The removal of the type 1 diabetes indication is not due to any new safety concerns and the other indications of dapaglifl…